Publication | Closed Access
Efficacy and safety of high-dose cabergoline in Parkinson's disease
27
Citations
15
References
2005
Year
High-dose cabergoline was well tolerated and provided significant improvements in the Parkinson symptomatology and a reduced requirement for L-dopa.
| Year | Citations | |
|---|---|---|
Page 1
Page 1